Testing new DETERMINE banner

 

 

 

DETERMINE for patients

 

 

About DETERMINE

DETERMINE is a tumour agnostic trial. This means that it doesn’t matter what type of cancer you have, or where it started in the body. 

Eligibility criteria 

Adults, teenagers and children who have a genetic change in their cancer (e.g. a rare form of cancer, or a common form of cancer with a rare genetic change). Your tumour must be screened for actionable genetic alterations prior to the trial. This can be done through the NHS Genomics Medicine Service. 

In addition, patients must meet the following: 

  • exhausted (or declined) standard-of-care treatment options 
  • no effective standard treatment available 
  • disease progression on previous treatments 

Learn more about DETERMINE

Find out about our open treatment arms

 

 

 

What is DETERMINE and what to expect

 

 

I was given a drug that was usually used to treat breast cancer and in my case the response has been superb, with scans showing great improvements. It is like a fairytale. This drug is keeping me alive.

—Simon, DETERMINE trial patient

 

 

 

How to take part

Two scientists reviewing results. They are both in lab coats and in a laboratory setting.

Centre for Drug Development

The Cancer Research UK Centre for Drug Development (CDD) partners with academics, biotech, and pharma to deliver early-phase clinical trials, accelerating the next generation of cancer treatments to patients. 

Three people walking down the street chatting to each other.

Patient Involvement

Cancer Research UK actively involves people affected by cancer in their work. This insight is helping beat cancer sooner while ensuring the needs of patients and their families and loved ones are met. 

A man wearing a headset, speaking on a call. He appears to be working in an office as you can see others behind him.

Cancer Chat 

Cancer Chat is Cancer Research UK's fully moderated forum where you can talk to others affected by cancer, share experiences, and get support. Cancer Chat is free to join and available 24 hours a day.